In general, this issue occurs in less than 10 percent of people on these medications, and is the reason why periodic blood work monitoring is necessary.
Ngokuthe gabalala, le nto yenzeka kumyinge ongaphantsi kwe-10 lephesenti kubantu abasebenzisa la mayeza yaye kusisizathu esibangela ukuba kube yimfuneko ukuthi gqolo kuqwalaselwa iziphumo zegazi.